Celebrex Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Low- vs High-Intensity Walking for PAD, Celecoxib for Stage III CRC, N95 Reprocessing Review, and more
Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the April 6, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - April 6, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Does Breast Cancer Risk REACT to Celecoxib?
Does this COX-2 inhibitor alter breast cancer risk? Dr Kathy Miller discusses the results of the REACT trial with its primary investigator, Dr Charles Coombes. (Source: Medscape Oncology)
Source: Medscape Oncology - December 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts